BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18765684)

  • 1. Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites.
    Sanderson JP; Hollis FJ; Maggs JL; Clarke SE; Naisbitt DJ; Park BK
    Drug Metab Dispos; 2008 Dec; 36(12):2424-8. PubMed ID: 18765684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes.
    Cribb AE; Spielberg SP; Griffin GP
    Drug Metab Dispos; 1995 Mar; 23(3):406-14. PubMed ID: 7628308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers.
    Mitra AK; Thummel KE; Kalhorn TF; Kharasch ED; Unadkat JD; Slattery JT
    Clin Pharmacol Ther; 1996 Mar; 59(3):332-40. PubMed ID: 8653996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine.
    Cribb AE; Spielberg SP
    Drug Metab Dispos; 1990; 18(5):784-7. PubMed ID: 1981737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by atovaquone of CYP2C9-mediated sulphamethoxazole hydroxylamine formation.
    Miller JL; Trepanier LA
    Eur J Clin Pharmacol; 2002 Apr; 58(1):69-72. PubMed ID: 11956677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
    Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
    Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfamethoxazole is metabolized to the hydroxylamine in humans.
    Cribb AE; Spielberg SP
    Clin Pharmacol Ther; 1992 May; 51(5):522-6. PubMed ID: 1587066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C8- and CYP3A-mediated C-demethylation of (3-{[(4-tert-butylbenzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid (CP-533,536), an EP2 receptor-selective prostaglandin E2 agonist: characterization of metabolites by high-resolution liquid chromatography-tandem mass spectrometry and liquid chromatography/mass spectrometry-nuclear magnetic resonance.
    Prakash C; Wang W; O'Connell T; Johnson KA
    Drug Metab Dispos; 2008 Oct; 36(10):2093-103. PubMed ID: 18653741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients.
    Goda R; Nagai D; Akiyama Y; Nishikawa K; Ikemoto I; Aizawa Y; Nagata K; Yamazoe Y
    Drug Metab Dispos; 2006 May; 34(5):828-35. PubMed ID: 16507648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
    Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
    Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry.
    Rüfer CE; Glatt H; Kulling SE
    Drug Metab Dispos; 2006 Jan; 34(1):51-60. PubMed ID: 16199471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
    Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
    Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing and minimizing time-dependent inhibition of cytochrome P450 3A in drug discovery: a case study with melanocortin-4 receptor agonists.
    Tang W; Stearns RA; Wang RW; Miller RR; Chen Q; Ngui J; Bakshi RK; Nargund RP; Dean DC; Baillie TA
    Xenobiotica; 2008 Nov; 38(11):1437-51. PubMed ID: 18841517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
    Deo AK; Bandiera SM
    Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes.
    Li W; Liu Y; He YQ; Zhang JW; Gao Y; Ge GB; Liu HX; Huo H; Liu HT; Wang LM; Sun J; Wang Q; Yang L
    Xenobiotica; 2008 Dec; 38(12):1551-65. PubMed ID: 18982531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) revisited: comparative cytochrome P450 inhibition in human liver microsomes by SKF525A, its metabolites, and SKF-acid and SKF-alcohol.
    Franklin MR; Hathaway LB
    Drug Metab Dispos; 2008 Dec; 36(12):2539-46. PubMed ID: 18799803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new flavone-8-acetic acid metabolites using mouse microsomes and comparison with human microsomes.
    Pham MH; Auzeil N; Regazzetti A; Dauzonne D; Dugay A; Menet MC; Scherman D; Chabot GG
    Drug Metab Dispos; 2007 Nov; 35(11):2023-34. PubMed ID: 17664249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub one minute inhibition assays for the major cytochrome P450 enzymes utilizing ultra-performance liquid chromatography/tandem mass spectrometry.
    Rainville PD; Wheaton JP; Alden PG; Plumb RS
    Rapid Commun Mass Spectrom; 2008 May; 22(9):1345-50. PubMed ID: 18381621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878), a novel 5-hydroxytryptamine (5-HT)1A agonist/5-HT3 antagonist, in human hepatic cytochrome P450 enzymes.
    Minato K; Suzuki R; Asagarasu A; Matsui T; Sato M
    Drug Metab Dispos; 2008 May; 36(5):831-40. PubMed ID: 18238859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of novel adenine dinucleotide phosphate conjugates of imatinib in incubations with rat and human liver microsomes.
    Ma S; Subramanian R; Xu Y; Schrag M; Shou M
    Drug Metab Dispos; 2008 Dec; 36(12):2414-8. PubMed ID: 18799804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.